Richard Ronald
SEC Form 4 insider trading activity
Richard Ronald has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.
On the most recent filing, Richard Ronald is listed as Director at Emergent BioSolutions Inc. Inside the rolling window, Richard Ronald reported no open-market purchases and 1 open-market sale totaling $263K in EBS.
Companies traded
Other insiders at EBS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$263K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Richard Ronald made?
Richard Ronald has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Richard Ronald trade?
Richard Ronald has filed SEC Form 4 disclosures for 1 company, including EBS.
When was Richard Ronald's most recent SEC Form 4 filing?
Richard Ronald's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.
What is Richard Ronald's total buy and sell value in the current window?
Inside the rolling retention window, Richard Ronald bought $0 and sold $263K based on SEC Form 4 filings.
What was Richard Ronald's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 21,984 EBS shares on 2025-12-05, worth $263K, per SEC Form 4 filings.